
LYV · NYSE
The supplied consensus is Buy across 16 analysts, with a mean price target of $209; low and high targets are not reported, so the full target spread cannot be measured. Other cited services show published targets clustered around $184.78, $190.90 and $193.05, while Susquehanna is the least bullish named analyst at Neutral with a $186 target. The evidence does not identify the most bullish analyst. Revisions were mixed over the past week: Susquehanna cut its rating but raised its target from $181 to $186. The substantive disagreement is whether record demand and the second-quarter beat can overcome valuation, cost, debt and legal risks.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Susquehanna | — | $186 | +8.5% | Aug 3, 2026 | Open the report this row came from |